Viewing Study NCT03557359


Ignite Creation Date: 2025-12-24 @ 2:25 PM
Ignite Modification Date: 2026-01-27 @ 6:37 AM
Study NCT ID: NCT03557359
Status: COMPLETED
Last Update Posted: 2025-11-03
First Post: 2018-05-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Nivolumab for Recurrent or Progressive IDH Mutant Gliomas
Sponsor: Fabio Iwamoto, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gliomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recurrent View
None Progressive View
None High Grade Glioma View
None IDH Mutant View
None Low Grade Glioma View